Work

Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients

Year: 2026

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2026.2666850

Authors: Megan Metzger, Julian A. Waksal, Jayanshu Jain, Natalia Rosas, Margherita Maffioli, Grace Van Hyfte, Aaron Gerds, Vikas Gupta, Francesco Passamonti, Abdulraheem Yacoub, Ronald Hoffman, John O. Mascarenhas

Institutions: Tisch Cancer Institute, New York University, The Ohio State University Wexner Medical Center, The Ohio State University, Aziende Socio Sanitarie Territoriale dei Sette Laghi, Cleveland Clinic, University Health Network, Princess Margaret Cancer Centre, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Kansas, University of Kansas Medical Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7161547557

FWCI:

Cites: 10

Cited by:

Related to: